PCOS/PMOS: Tests Your Doctor Should Consider

If you live with PCOS/PMOS, your doctor may order blood tests that seem to have nothing to do with your ovaries. A1C. Fasting insulin. HOMA-IR. Why are these metabolic labs on your list?

The answer is tied to a big change in how experts describe the condition. In May 2026, PCOS got a new name: polyendocrine metabolic ovarian syndrome, or PMOS. The word "metabolic" is now part of the name.

This guide explains what PMOS means, why metabolic labs often come up, and what each test measures. It does not tell you what your own results mean. That conversation belongs with your healthcare provider.

Why Your Doctor May Check Metabolic Labs in PCOS/PMOS

Research shows that many people with PMOS have insulin resistance. Insulin is a hormone that helps move sugar from your blood into your cells for energy. With insulin resistance, cells respond less strongly to insulin, so the body may make more of it.

The 2023 International Evidence-based Guideline for PCOS notes a higher rate of prediabetes and type 2 diabetes in people with the condition, at any body weight. It recommends checking blood sugar status at diagnosis and every one to three years after, based on other risk factors. The guideline lists three tests for this: an oral glucose tolerance test (OGTT), fasting glucose, or A1C. It names the OGTT as the most accurate of the three in PMOS.

So when your doctor orders these labs, they are often looking at the "metabolic" part of PMOS.

What Is the A1C Test?

The A1C test (also called hemoglobin A1C or HbA1c) shows your average blood sugar over about the past three months. Hemoglobin is a protein inside red blood cells. When sugar is in your blood, some of it sticks to hemoglobin. The A1C test measures what percent of your hemoglobin has sugar attached.

Why three months? Red blood cells live for roughly that long before your body replaces them. So the A1C reflects a longer stretch of time than a single finger-stick reading, which only shows one moment.

The A1C test does not usually require fasting. According to the Centers for Disease Control and Prevention (CDC), results are grouped into these ranges:

For people with PMOS, research suggests A1C may miss some blood sugar changes that an OGTT can detect. That is one reason a provider may order more than one test. Only a healthcare provider can interpret these numbers for you.

What Does a Fasting Insulin Test Measure?

A fasting insulin test measures how much insulin is in your blood after you have not eaten for a set time, often 8 to 12 hours. Your lab or doctor will give you the exact instructions.

While A1C looks at sugar, this test looks at the hormone that manages sugar. Some people have normal blood sugar while their body makes extra insulin to keep it there. That is why fasting insulin often comes up in conversations about PMOS.

Here is something many people don't know: fasting insulin has no single, universal reference range. Different labs use different test kits, called assays. A 2025 study in Clinical Chemistry and Laboratory Medicine compared 12 commercial insulin assays. It found that results still varied a lot between them, even though all claimed to follow the same reference standard.

This means a number from one lab may not match a number from another lab. Your report will usually list that lab's own reference range next to your result.

What Is HOMA-IR?

HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It is not a separate blood draw. It is a number calculated from two fasting results: your fasting glucose and your fasting insulin.

Researchers David Matthews and colleagues first described this model in 1985 in the journal Diabetologia. They compared its estimates against a detailed research test called the clamp method and found a strong link between the two. The common shortcut formula, using glucose in mg/dL and insulin in µU/mL, is:

A higher number suggests the body is using more insulin to keep fasting blood sugar steady. Still, HOMA-IR is an estimate, not a diagnosis. Its authors later warned in a 2004 review that the model can be misused when its limits are ignored.

There is also no single agreed cutoff for HOMA-IR. Studies use different numbers depending on age, ethnicity and the insulin assay used. Because HOMA-IR depends on fasting insulin, the lab differences described above carry over into this score.

This matters for PMOS. The 2023 PCOS guideline does not recommend measuring insulin resistance in routine clinical care, because current insulin tests have limited clinical value. Some providers still order fasting insulin or HOMA-IR. If yours does, it is fair to ask how they plan to use the result.

How These Metabolic Labs Fit Together

Each test shows a different piece of the picture. A1C reflects average blood sugar over months. Fasting insulin shows insulin at one moment. HOMA-IR combines fasting insulin and glucose into one estimate. Because they measure different things, results don't always line up, which is why providers look at them together with your history.

Factors That Can Influence Your Results

Lab numbers are not fixed. Many everyday and medical factors can affect them. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) notes that some conditions can make A1C less accurate. These include:

• Certain types of anemia or blood loss, which change how long red blood cells live.
• Hemoglobin variants, which are inherited differences in hemoglobin that some test methods read differently.
• Kidney disease and pregnancy, which can also shift A1C readings.

Fasting insulin and HOMA-IR can be influenced by other factors, such as:

• How long you fasted before the blood draw.
• Recent illness, poor sleep or stress, which affect hormones involved in blood sugar.
• Some medications, including steroids.
• The lab and assay used, as described earlier.

This is why a single result is usually seen as one data point, not the full story.

Questions People With PCOS/PMOS Often Bring to Their Doctor

Many people find it helpful to write down questions before an appointment. Some common ones include:

• Which metabolic labs did you order, and what are you looking for?
• Would an oral glucose tolerance test give you more information in my case?
• What reference range does this lab use for fasting insulin?
• How often should my blood sugar status be checked?
• Will my records now say PMOS instead of PCOS?

The Bottom Line

The new name PMOS reflects what researchers have learned: this condition involves hormones and metabolism, not just the ovaries. That is why metabolic labs like A1C, fasting insulin and HOMA-IR may show up on your lab order.

Each test offers a different view, and none tells the whole story on its own. Knowing what they measure can help you ask clearer questions and take an active part in conversations about your health.

Sources

1. Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. 2026. doi:10.1016/S0140-6736(26)00717-8.
2. Endocrine Society. PCOS name change press release. May 2026.
3. Monash University. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care. May 2026.
4. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. European Journal of Endocrinology. 2023;189:G43–64.
5. Diagnostic accuracy of oral glucose tolerance tests, fasting plasma glucose and HbA1c for type 2 diabetes in women with PCOS. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2024;18(3):102970.
6. Centers for Disease Control and Prevention. A1C Test for Diabetes and Prediabetes.
7. National Institute of Diabetes and Digestive and Kidney Diseases. The A1C Test & Diabetes.
8. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
9. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495.
10. Rohlfing C, Petroski G, Hatten-Beck M, et al. The current status of serum insulin measurements and the need for standardization. Clinical Chemistry and Laboratory Medicine. 2025.